Mar Guasp

1.5k total citations
33 papers, 578 citations indexed

About

Mar Guasp is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Mar Guasp has authored 33 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 10 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Mar Guasp's work include Autoimmune Neurological Disorders and Treatments (24 papers), Peripheral Neuropathies and Disorders (14 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Mar Guasp is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (24 papers), Peripheral Neuropathies and Disorders (14 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Mar Guasp collaborates with scholars based in Spain, United States and Japan. Mar Guasp's co-authors include Josep Dalmau, Eugenia Martínez‐Hernández, Francesc Graus, Albert Saiz, Helena Ariño, Thaís Armangué, Raquel Ruiz‐García, Laura Naranjo, Carles Gaig and Domingo Escudero and has published in prestigious journals such as Journal of Clinical Investigation, Neurology and Clinical Infectious Diseases.

In The Last Decade

Mar Guasp

27 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mar Guasp Spain 13 479 109 87 75 66 33 578
James Varley United Kingdom 7 420 0.9× 134 1.2× 49 0.6× 48 0.6× 86 1.3× 14 488
Katarzyna D. Bera United Kingdom 4 743 1.6× 77 0.7× 253 2.9× 110 1.5× 22 0.3× 9 824
A. Vincent United Kingdom 8 651 1.4× 50 0.5× 106 1.2× 48 0.6× 88 1.3× 12 732
Mareike Schimmel Germany 8 310 0.6× 31 0.3× 58 0.7× 36 0.5× 206 3.1× 28 424
Daniela Alberti Italy 14 276 0.6× 42 0.4× 14 0.2× 31 0.4× 133 2.0× 21 431
Ana Felipe‐Rucián Spain 5 226 0.5× 33 0.3× 54 0.6× 51 0.7× 33 0.5× 15 290
Jesse Cohen United States 5 269 0.6× 49 0.4× 51 0.6× 86 1.1× 10 0.2× 7 311
Ashwin Pinto United Kingdom 13 320 0.7× 67 0.6× 13 0.1× 39 0.5× 40 0.6× 35 543
Alexander Carvajal-González United States 5 383 0.8× 19 0.2× 80 0.9× 46 0.6× 22 0.3× 9 417
Julien Hébert United States 8 211 0.4× 30 0.3× 34 0.4× 42 0.6× 28 0.4× 31 283

Countries citing papers authored by Mar Guasp

Since Specialization
Citations

This map shows the geographic impact of Mar Guasp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar Guasp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar Guasp more than expected).

Fields of papers citing papers by Mar Guasp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mar Guasp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar Guasp. The network helps show where Mar Guasp may publish in the future.

Co-authorship network of co-authors of Mar Guasp

This figure shows the co-authorship network connecting the top 25 collaborators of Mar Guasp. A scholar is included among the top collaborators of Mar Guasp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mar Guasp. Mar Guasp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Businaro, Pietro, Laura Naranjo, Jesús Planagumà, et al.. (2025). Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II). Neurology Neuroimmunology & Neuroinflammation. 12(4). e200406–e200406. 2 indexed citations
2.
Planagumà, Jesús, et al.. (2025). Autoimmune neuropsychiatric disorders manifesting with psychosis. Journal of Clinical Investigation. 135(20).
3.
Guasp, Mar & Josep Dalmau. (2024). Predicting the future of autoimmune encephalitides. Revue Neurologique. 180(9). 862–875.
4.
Sepúlveda, María, Raquel Ruiz‐García, Núria Martínez‐Cibrián, et al.. (2024). CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD. Neurology Neuroimmunology & Neuroinflammation. 11(5). e200292–e200292. 16 indexed citations
5.
Olivé-Cirera, Gemma, Arlette L. Bruijstens, Li‐Wen Chen, et al.. (2024). MOG Antibodies Restricted to CSF in Children With Inflammatory CNS Disorders. Neurology. 102(7). e209199–e209199. 6 indexed citations
6.
Muñoz‐Lopetegi, Amaia, Mar Guasp, Eugenia Martínez‐Hernández, et al.. (2024). Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study. The Lancet Neurology. 23(3). 256–266. 16 indexed citations
7.
Wright, Melissa A., Mar Guasp, Christian Lachner, et al.. (2024). Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature. Journal of Neuroimmunology. 392. 578369–578369. 2 indexed citations
8.
Chen, Li‐Wen, Mar Guasp, Gemma Olivé-Cirera, et al.. (2023). Antibody Investigations in 2,750 Children With Suspected Autoimmune Encephalitis. Neurology Neuroimmunology & Neuroinflammation. 11(1). 8 indexed citations
9.
Leypoldt, Frank, Jérôme Honnorat, Josep Dalmau, et al.. (2023). Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis, Already at Diagnosis: The NEOS2 Model. (P5-5.009). Neurology. 100(17_supplement_2). 1 indexed citations
10.
Guasp, Mar, Eugenia Martínez‐Hernández, Daniel Santana, et al.. (2022). CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome. Frontiers in Immunology. 13. 866153–866153. 62 indexed citations
11.
Sepúlveda, María, Sara Llufriú, Eugenia Martínez‐Hernández, et al.. (2021). Incidence and Impact of COVID-19 in MS. Neurology Neuroimmunology & Neuroinflammation. 8(2). 28 indexed citations
12.
Anmella, Gerard, et al.. (2021). Thyrotoxic Psychosis Associated With Amiodarone. Journal of Clinical Psychopharmacology. 41(3). 342–344.
13.
Martínez‐Hernández, Eugenia, María Sepúlveda, Sara Llufriú, et al.. (2021). Incidence and impact of COVID-19 in a cohort of patients with myasthenia gravis from Barcelona. (4170). Neurology. 96(15_supplement). 1 indexed citations
14.
Ruiz‐García, Raquel, Laura Naranjo, Mar Guasp, et al.. (2021). Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis. Frontiers in Immunology. 12. 691536–691536. 57 indexed citations
15.
Martínez‐Hernández, Eugenia, Mar Guasp, Anna García‐Serra, et al.. (2020). Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies. Neurology. 94(22). e2302–e2310. 83 indexed citations
16.
Petit‐Pedrol, Mar, Mar Guasp, Thaís Armangué, et al.. (2020). Absence of GluD2 Antibodies in Patients With Opsoclonus-Myoclonus Syndrome. Neurology. 96(7). e1082–e1087. 7 indexed citations
17.
Guanyabens, Nicolau, et al.. (2020). Cycloid psychosis as a psychiatric expression of anti‐NMDAR encephalitis. A systematic review of case reports accomplished with the authors' cooperation. Brain and Behavior. 11(2). e01980–e01980. 15 indexed citations
18.
19.
Guasp, Mar & Josep Dalmau. (2017). Encefalitis por anticuerpos contra el receptor de NMDA. Medicina Clínica. 151(2). 71–79. 42 indexed citations
20.
Guasp, Mar, Núria Solà‐Valls, Eugenia Martínez‐Hernández, et al.. (2016). Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67). Journal of Neuroimmunology. 300. 15–17. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Varley Breakdown of academic impact, for papers by Katarzyna D. Bera Breakdown of academic impact, for papers by A. Vincent Breakdown of academic impact, for papers by Mareike Schimmel Breakdown of academic impact, for papers by Daniela Alberti Breakdown of academic impact, for papers by Ana Felipe‐Rucián Breakdown of academic impact, for papers by Jesse Cohen Breakdown of academic impact, for papers by Ashwin Pinto Breakdown of academic impact, for papers by Alexander Carvajal-González Breakdown of academic impact, for papers by Julien Hébert
Rankless by CCL
2026